Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 462

1.

Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.

Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R.

Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):246-52. doi: 10.1002/pds.1710.

PMID:
19148882
2.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.

N Engl J Med. 2006 Feb 9;354(6):579-87.

3.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
4.

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.

Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S.

JAMA. 2015 Jun 2;313(21):2142-51. doi: 10.1001/jama.2015.5605.

5.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
6.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
7.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
8.

Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.

Wilson KL, Zelig CM, Harvey JP, Cunningham BS, Dolinsky BM, Napolitano PG.

Am J Perinatol. 2011 Jan;28(1):19-24. doi: 10.1055/s-0030-1262507. Epub 2010 Jul 6.

PMID:
20607643
9.

Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.

Alano MA, Ngougmna E, Ostrea EM Jr, Konduri GG.

Pediatrics. 2001 Mar;107(3):519-23.

PMID:
11230592
10.

SSRI antidepressants and persistent pulmonary hypertension in newborns.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):156.

PMID:
19492488
11.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
12.

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.

Källén B, Olausson PO.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):801-6. doi: 10.1002/pds.1570.

PMID:
18314924
13.

Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.

Galbally M, Lewis AJ, Lum J, Buist A.

Aust N Z J Psychiatry. 2009 Sep;43(9):846-54. doi: 10.1080/00048670903107583.

PMID:
19670058
14.
15.

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A.

Pediatrics. 2007 Jan;119(1):52-9.

PMID:
17200271
16.

Neonate characteristics after maternal use of antidepressants in late pregnancy.

Källén B.

Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6.

PMID:
15066868
17.

Duration of antidepressant use during pregnancy and risk of major congenital malformations.

Ramos E, St-André M, Rey E, Oraichi D, Bérard A.

Br J Psychiatry. 2008 May;192(5):344-50. doi: 10.1192/bjp.bp.107.042523.

18.

Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.

Koren G, Boucher N.

Can J Clin Pharmacol. 2009 Winter;16(1):e66-7. Epub 2009 Jan 22. Review.

PMID:
19164848
19.

Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.

Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.

Ann Epidemiol. 2013 Nov;23(11):681-7. doi: 10.1016/j.annepidem.2013.08.005. Epub 2013 Oct 7.

PMID:
24113367
20.

Bupropion in pregnancy and the prevalence of congenital malformations.

Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):474-84.

PMID:
16897811

Supplemental Content

Support Center